Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01584999
Other study ID # Prot 210163
Secondary ID
Status Completed
Phase Phase 4
First received April 23, 2012
Last updated May 21, 2012
Start date February 2011

Study information

Verified date May 2012
Source Università Politecnica delle Marche
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics Committee
Study type Interventional

Clinical Trial Summary

Aim of the study is to evaluate the effects, on microcirculation of septic patient, of three types of RBCs: 1- fresh standard RBCs (storage <10 days); 2-leukodepleted RBCs and 3-old standard RBCs (storage >15 days) respectively. Before and 1 hour after the transfusion, microcirculation is evaluated using Sidestream Dark Field Imaging (SDF) and Near InfraRed Spectroscopy (NIRS) with vascular occlusion test. We also monitor temperature, heart rate, mean blood pressure, hemochrome, blood gases, blood lactates and SOFA score.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date
Est. primary completion date February 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with sepsis, severe sepsis or septic shock who, according to clinical evaluation, need a hemotransfusion.

Exclusion Criteria:

- Patients under 18 years of age; Pregnancy; Coagulative disorders; Cardiogenic shock (Met<4;)Acute massive bleeding (>8 U)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Biological:
Blood transfusion
RBCs have been transfused in septic patient admitted in ICU

Locations

Country Name City State
Italy University ICU, AOU Ospedali Riuniti Torrette di Ancona Ancona

Sponsors (2)

Lead Sponsor Collaborator
Università Politecnica delle Marche Azienda Ospedaliero, Universitaria Ospedali Riuniti

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Microcirculatory Flow Index (MFI) before and after blood transfusion. Microcirculatory Flow Index detected in vivo by side-dark field imaging at sublingual microcirculation. It represents the quality of blood flow at microcirculatory level. This study wants to verify any of the considered different types of blood transfused can improve MFI. One hour after the end of blood transfusion compared with before blood transfusion No
Secondary Perfused Vessel Density (PVD) Perfused Vessel Density detected in vivo by side-dark field imaging at sublingual microcirculation. It represents the quantity of well perfused vessels at microcirculatory level. This study wants to verify any of the considered different types of blood transfused can improve PVD. One hour after the end of blood transfusion compared with before blood transfusion No
Secondary StO2 upslope StO2 upslope is measured with Near InfraRed Spectroscopy at the tenar muscle. It represents the velocity of the recovery of the tissue oxygen saturation after a short period of ischemia of the hand, the Vascular Occlusion Test. One hour after the end of blood transfusion compared with before blood transfusion No
Secondary Arterial Blood Lactate One hour after the end of blood transfusion compared with before blood transfusion No
Secondary Arterial pH One hour after the end of blood transfusion compared with before blood transfusion No
Secondary SOFA score One hour after the end of blood transfusion compared with before blood transfusion No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03853005 - Effect of High volumeHemodiafiltration on Lung Oxygenation and Mechanics N/A
Completed NCT03359369 - Prognostic Value of Serum Cholesterol and Triglyceride in Septic and Non Septic Patients